Abstract
Objective
To rank clinician-driven tests and treatments (CTTs) by their total cost during the birth hospitalization for preterm infants.
Study design
Retrospective cohort of very low birth weight (<1500 g) and/or very preterm (<32 weeks) subjects admitted to US children’s hospital Neonatal Intensive Care Units (2012–2018). CTTs were defined as pharmaceutical, laboratory and imaging services and ranked by total cost.
Results
24,099 infants from 51 hospitals were included. Parenteral nutrition ($85M, 32% of pharmacy costs), blood gas analysis ($34M, 29% of laboratory costs), and chest radiographs ($18M, 31% of imaging costs) were the costliest CTTs overall. More than half of CTT-related costs occurred during 10% of hospital days.
Conclusions
The majority of CTT-related costs were from commonly used tests and treatments. Targeted efforts to improve value in neonatal care may benefit most from focusing on reducing unnecessary utilization of common tests and treatments, rather than infrequently used ones.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Keren R, Luan X, Localio R, Hall M, McLeod L, Dai D, et al. Prioritization of comparative effectiveness research topics in hospital pediatrics. Arch Pediatr Adolesc Med. 2012;166:1155–64.
Dukhovny D, Pursley DM, Kirpalani HM, Horbar JH, Zupancic JA. Evidence, quality, and waste: solving the value equation in neonatology. Pediatrics. 2016;137:e20150312.
Ho T, Zupancic JAF, Pursley DM, Dukhovny D. Improving value in neonatal intensive care. Clin Perinatol. 2017;44:617–25.
Porter ME. What is value in health care? N Engl J Med. 2010;363:2477–81.
Wei D, Osman C, Dukhovny D, Romley J, Hall M, Chin S, et al. Cost consciousness among physicians in the neonatal intensive care unit. J Perinatol. 2016;36:1014–20.
Ho T, Dukhovny D, Zupancic JA, Goldmann DA, Horbar JD, Pursley DM. Choosing wisely in newborn medicine: five opportunities to increase value. Pediatrics. 2015;136:e482–9.
Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 2013;13:59.
Shwartz M, Young DW, Siegrist R. The ratio of costs to charges: how good a basis for estimating costs? Inquiry. 1995;32:476–81.
Finkler SA. The distinction between cost and charges. Ann Intern Med. 1982;96:102–9.
Dunn A, Grosse SD, Zuvekas SH. Adjusting health expenditures for inflation: a review of measures for health services research in the United States. Health Serv Res. 2018;53:175–96.
Rao JNK, Scott AJ. The analysis of categorical data from complex sample surveys: Chi-squared tests for goodness of fit and independence in two-way tables. J Am Stat Assoc. 1981;76:221–30.
Richardson DK, Zupancic JA, Escobar GJ, Ogino M, Pursley DM, Mugford M. A critical review of cost reduction in neonatal intensive care. II. Strategies for reduction. J Perinatol. 2001;21:121–7.
Arjaans S, Zwart EAH, Ploegstra MJ, Bos AF, Kooi EMW, Hillege HL, et al. Identification of gaps in the current knowledge on pulmonary hypertension in extremely preterm infants: a systematic review and meta-analysis. Paediatr Perinat Epidemiol. 2018;32:258–67.
Sankar MN, Bhombal S, Benitz WE. PDA: To treat or not to treat. Congenit Heart Dis. 2019;14:46–51.
Suresh G, King BC, Jain SK. Screening for pulmonary hypertension in preterm infants-not ready for prime time. J Perinatol. 2018;38:206–10.
Barrington KJ, Finer N, Pennaforte T. Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev. 2017;1:CD000509.
Soll RF. Inhaled nitric oxide for preterm infants: what can change our practice? Pediatrics. 2018;141;e20174214.
Kelly LE, Ohlsson A, Shah PS. Sildenafil for pulmonary hypertension in neonates. Cochrane Database Syst Rev. 2017;8:CD005494.
Ng G, Da Silva O, Ohlsson A. Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants. Cochrane Database Syst Rev. 2016;12:CD003214.
Stewart A, Brion LP. Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev. 2011;9:CD001453.
Goodman DC, Ganduglia-Cazaban C, Franzini L, Stukel TA, Wasserman JR, Murphy MA, et al. Neonatal intensive care variation in medicaid-insured newborns: a population-based study. J Pediatr. 2019;209:44–51.e2.
Kaplan HC, Tabangin ME, McClendon D, Meinzen-Derr J, Margolis PA, Donovan EF. Understanding variation in vitamin A supplementation among NICUs. Pediatrics. 2010;126:e367–73.
Slaughter JL, Stenger MR, Reagan PB. Variation in the use of diuretic therapy for infants with bronchopulmonary dysplasia. Pediatrics. 2013;131:716–23.
Slaughter JL, Stenger MR, Reagan PB, Jadcherla SR. Utilization of inhaled corticosteroids for infants with bronchopulmonary dysplasia. PLoS ONE. 2014;9:e106838.
Stenger MR, Slaughter JL, Kelleher K, Shepherd EG, Klebanoff MA, Reagan P, et al. Hospital variation in nitric oxide use for premature infants. Pediatrics. 2012;129:e945–51.
Rogowski J. Using economic information in a quality improvement collaborative. Pediatrics. 2003;111:e411–8.
Synhorst DC, Johnson MB, Bettenhausen JL, Kyler KE, Richardson TE, Mann KJ, et al. Room costs for common pediatric hospitalizations and cost-reducing quality initiatives. Pediatrics. 2020;145:e20192177.
Phibbs CS, Schmitt SK, Cooper M, Gould JB, Lee HC, Profit J, et al. Birth hospitalization costs and days of care for mothers and neonates in California, 2009-2011. J Pediatr. 2019;204:118–25.e14.
Russell RB, Green NS, Steiner CA, Meikle S, Howse JL, Poschman K, et al. Cost of hospitalization for preterm and low birth weight infants in the United States. Pediatrics. 2007;120:e1–9.
Zupancic JA, Hibbs AM, Palermo L, Truog WE, Cnaan A, Black DM, et al. Economic evaluation of inhaled nitric oxide in preterm infants undergoing mechanical ventilation. Pediatrics. 2009;124:1325–32.
Author information
Authors and Affiliations
Contributions
Conceptualization/design/methodology and Manuscript editing: BCK, TR, MH, NAB, HCL, KSG, JLS, RMP, SWP. Investigation/formal analysis and Manuscript drafting: BCK, TR, JLS. All authors gave final approval of the version to be published. All authors agree to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
King, B.C., Richardson, T., Patel, R.M. et al. Cost of clinician-driven tests and treatments in very low birth weight and/or very preterm infants. J Perinatol 41, 295–304 (2021). https://doi.org/10.1038/s41372-020-00879-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41372-020-00879-6
This article is cited by
-
Managing established bronchopulmonary dysplasia without using routine blood gas measurements
Journal of Perinatology (2024)
-
Association of the respiratory severity score with bronchopulmonary dysplasia-associated pulmonary hypertension in infants born extremely preterm
Journal of Perinatology (2024)
-
Hospital variation in neonatal echocardiography among very preterm infants at US children’s hospitals
Journal of Perinatology (2023)
-
Prevention of Preterm Birth by Cervical Pessary Combined with Vaginal Progesterone: a Systematic Review and Meta-analysis with Trial Sequential Analysis
Reproductive Sciences (2023)
-
Non-invasive continuous cardiac output monitoring in infants with hypoxic ischaemic encephalopathy
Journal of Perinatology (2022)